MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice

During inflammation and infection, hematopoietic stem and progenitor cells are stimulated to proliferate and differentiate into mature immune cells, especially of the myeloid lineage. MicroRNA-146a (miR-146a) is a critical negative regulator of inflammation. Deletion of miR-146a produces effects tha...

Full description

Bibliographic Details
Main Authors: Jimmy L Zhao, Dinesh S Rao, Ryan M O’Connell, Yvette Garcia-Flores, David Baltimore
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2013-05-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/00537
_version_ 1811180635629289472
author Jimmy L Zhao
Dinesh S Rao
Ryan M O’Connell
Yvette Garcia-Flores
David Baltimore
author_facet Jimmy L Zhao
Dinesh S Rao
Ryan M O’Connell
Yvette Garcia-Flores
David Baltimore
author_sort Jimmy L Zhao
collection DOAJ
description During inflammation and infection, hematopoietic stem and progenitor cells are stimulated to proliferate and differentiate into mature immune cells, especially of the myeloid lineage. MicroRNA-146a (miR-146a) is a critical negative regulator of inflammation. Deletion of miR-146a produces effects that appear as dysregulated inflammatory hematopoiesis, leading to a decline in the number and quality of hematopoietic stem cells (HSCs), excessive myeloproliferation, and, ultimately, to HSC exhaustion and hematopoietic neoplasms. At the cellular level, the defects are attributable to both an intrinsic problem in the miR-146a–deficient HSCs and extrinsic effects of lymphocytes and nonhematopoietic cells. At the molecular level, this involves a molecular axis consisting of miR-146a, signaling protein TRAF6, transcriptional factor NF-κB, and cytokine IL-6. This study has identified miR-146a to be a critical regulator of HSC homeostasis during chronic inflammation in mice and provided a molecular connection between chronic inflammation and the development of bone marrow failure and myeloproliferative neoplasms.
first_indexed 2024-04-11T09:06:29Z
format Article
id doaj.art-bb1ca122fc784a52b8f89a38fa3a1437
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-11T09:06:29Z
publishDate 2013-05-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-bb1ca122fc784a52b8f89a38fa3a14372022-12-22T04:32:37ZengeLife Sciences Publications LtdeLife2050-084X2013-05-01210.7554/eLife.00537MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in miceJimmy L Zhao0Dinesh S Rao1Ryan M O’Connell2Yvette Garcia-Flores3David Baltimore4Department of Biology, California Institute of Technology, Pasadena, United StatesDepartment of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, United StatesDepartment of Pathology, University of Utah, Salt Lake City, United StatesDepartment of Biology, California Institute of Technology, Pasadena, United StatesDepartment of Biology, California Institute of Technology, Pasadena, United StatesDuring inflammation and infection, hematopoietic stem and progenitor cells are stimulated to proliferate and differentiate into mature immune cells, especially of the myeloid lineage. MicroRNA-146a (miR-146a) is a critical negative regulator of inflammation. Deletion of miR-146a produces effects that appear as dysregulated inflammatory hematopoiesis, leading to a decline in the number and quality of hematopoietic stem cells (HSCs), excessive myeloproliferation, and, ultimately, to HSC exhaustion and hematopoietic neoplasms. At the cellular level, the defects are attributable to both an intrinsic problem in the miR-146a–deficient HSCs and extrinsic effects of lymphocytes and nonhematopoietic cells. At the molecular level, this involves a molecular axis consisting of miR-146a, signaling protein TRAF6, transcriptional factor NF-κB, and cytokine IL-6. This study has identified miR-146a to be a critical regulator of HSC homeostasis during chronic inflammation in mice and provided a molecular connection between chronic inflammation and the development of bone marrow failure and myeloproliferative neoplasms.https://elifesciences.org/articles/00537hematopoiesisinflammationmicroRNAHSCcancerNF-kappaB
spellingShingle Jimmy L Zhao
Dinesh S Rao
Ryan M O’Connell
Yvette Garcia-Flores
David Baltimore
MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice
eLife
hematopoiesis
inflammation
microRNA
HSC
cancer
NF-kappaB
title MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice
title_full MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice
title_fullStr MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice
title_full_unstemmed MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice
title_short MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice
title_sort microrna 146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice
topic hematopoiesis
inflammation
microRNA
HSC
cancer
NF-kappaB
url https://elifesciences.org/articles/00537
work_keys_str_mv AT jimmylzhao microrna146aactsasaguardianofthequalityandlongevityofhematopoieticstemcellsinmice
AT dineshsrao microrna146aactsasaguardianofthequalityandlongevityofhematopoieticstemcellsinmice
AT ryanmoconnell microrna146aactsasaguardianofthequalityandlongevityofhematopoieticstemcellsinmice
AT yvettegarciaflores microrna146aactsasaguardianofthequalityandlongevityofhematopoieticstemcellsinmice
AT davidbaltimore microrna146aactsasaguardianofthequalityandlongevityofhematopoieticstemcellsinmice